Date published: 2026-5-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

KRTAP5 Inhibitors

KRTAP5 inhibitors are a class of chemical compounds designed to specifically interfere with the function of keratin-associated protein 5 (KRTAP5). KRTAPs, including the KRTAP5 family, play a critical role in the structure and organization of keratin, a fibrous protein that forms the main component of hair, nails, and the outer layer of skin. KRTAP5 proteins are part of a large multigene family and are particularly involved in the formation of the hair shaft, where they regulate the assembly and rigidity of keratin filaments. The inhibition of KRTAP5 disrupts the normal assembly of these keratin fibers, affecting the structural properties of keratinized tissues. By targeting these proteins, inhibitors can modulate the structural interactions between KRTAP5 and keratin, potentially leading to changes in the overall stability and organization of keratin networks.

Chemically, KRTAP5 inhibitors may interact with key functional domains in the KRTAP5 protein that are responsible for binding to keratin or other structural proteins. These inhibitors could act through direct binding to KRTAP5, leading to conformational changes that prevent its normal interaction with keratin. Alternatively, they may interfere with post-translational modifications or signaling pathways that regulate KRTAP5 expression or function. The structure of KRTAP5 inhibitors can vary widely, encompassing small organic molecules, peptides, or other synthetic compounds designed to bind with high specificity to the protein. By inhibiting KRTAP5 function, these compounds can provide insights into the mechanisms of keratin assembly and its role in maintaining the integrity of keratin-based structures.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

Actinomycin D may inhibit KRTAP5 expression by intercalating into DNA, blocking RNA synthesis and affecting transcription of KRTAP5.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$41.00
$84.00
$275.00
127
(6)

Cycloheximide might inhibit KRTAP5 expression by blocking protein synthesis, thereby reducing the production of KRTAP5 protein.

Chromomycin A3

7059-24-7sc-200907
10 mg
$260.00
(1)

Actinomycin C could potentially inhibit KRTAP5 expression similarly to Actinomycin D, by interfering with RNA synthesis.

Rifampicin

13292-46-1sc-200910
sc-200910A
sc-200910B
sc-200910C
1 g
5 g
100 g
250 g
$97.00
$328.00
$676.00
$1467.00
6
(1)

Rifampicin may inhibit KRTAP5 expression by targeting bacterial-like RNA polymerase, potentially affecting the transcription of KRTAP5.

Puromycin

53-79-2sc-205821
sc-205821A
10 mg
25 mg
$166.00
$322.00
436
(1)

Puromycin might inhibit KRTAP5 expression by prematurely terminating protein synthesis, thereby reducing KRTAP5 production.

Anisomycin

22862-76-6sc-3524
sc-3524A
5 mg
50 mg
$99.00
$259.00
36
(2)

Anisomycin has been suggested to inhibit KRTAP5 expression by inhibiting protein synthesis at the translational level, affecting KRTAP5 production.

Doxorubicin

23214-92-8sc-280681
sc-280681A
1 mg
5 mg
$176.00
$426.00
43
(3)

Doxorubicin may inhibit KRTAP5 expression by intercalating into DNA and impacting transcription, reducing the synthesis of KRTAP5.

Etoposide (VP-16)

33419-42-0sc-3512B
sc-3512
sc-3512A
10 mg
100 mg
500 mg
$51.00
$231.00
$523.00
63
(1)

Etoposide could potentially inhibit KRTAP5 expression by affecting topoisomerase II activity, influencing DNA transcription and KRTAP5 synthesis.

Blasticidin S Hydrochloride

3513-03-9sc-204655A
sc-204655
25 mg
100 mg
$367.00
$520.00
20
(2)

Blasticidin S may inhibit KRTAP5 expression by interfering with protein synthesis, potentially reducing the production of KRTAP5.

Mitomycin C

50-07-7sc-3514A
sc-3514
sc-3514B
2 mg
5 mg
10 mg
$66.00
$101.00
$143.00
85
(5)

Mitomycin C might inhibit KRTAP5 expression by crosslinking DNA, affecting transcription and potentially reducing KRTAP5 synthesis.